Hematology/Oncology

Top Story

VIDEO: Factor XI inhibitors offer potentially safer anticoagulant therapy

December 8, 2019
Meeting News

Treatment at safety net cancer center may overcome racial disparities in DLBCL outcomes

December 8, 2019
ORLANDO — White and nonwhite patients with de novo diffuse large B-cell lymphoma treated at a safety net cancer center demonstrated similar survival outcomes…
Meeting NewsPerspective

CAR T-cell therapy offers benefit, reduces health care utilization for older patients with DLBCL

December 8, 2019
ORLANDO — Older patients with multiple comorbidities can successfully undergo chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma, according to study…
Meeting News

‘Microvasculature on a chip’ may improve understanding of blood clots, therapy response

December 8, 2019
ORLANDO — A new microvascular-on-a-chip assay has allowed researchers to grow blood clots and track inflammatory thrombi with the goal of better targeting…
Meeting News

Tailored rivaroxaban regimens safe, effective for children with venous thromboembolism

December 8, 2019
ORLANDO — Body weight-adjusted regimens of rivaroxaban appeared to be safe and effective for children with venous thromboembolism, according to results of a…
More Headlines »
CME

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video
Meeting News

VIDEO: Sickle cell complications more frequent than previously thought

December 8, 2019
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Acute Lymphoblastic Leukemia Posters and Abstracts from San Diego

This activity is supported by educational funding provided by Amgen.

In this CME activity Elias Jabbour, MD, provides his perspectives on key posters presented at the American Society of…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next